Porto, Italo
 Distribuzione geografica
Continente #
NA - Nord America 10.303
EU - Europa 8.051
AS - Asia 7.096
SA - Sud America 1.329
Continente sconosciuto - Info sul continente non disponibili 384
AF - Africa 187
OC - Oceania 26
Totale 27.376
Nazione #
US - Stati Uniti d'America 10.051
DE - Germania 3.357
SG - Singapore 3.311
CN - Cina 1.732
BR - Brasile 1.061
SE - Svezia 1.052
IT - Italia 793
FR - Francia 683
VN - Vietnam 642
UA - Ucraina 567
GB - Regno Unito 427
IE - Irlanda 319
ID - Indonesia 228
IN - India 219
FI - Finlandia 187
BD - Bangladesh 159
RU - Federazione Russa 159
JP - Giappone 154
HK - Hong Kong 125
TR - Turchia 118
AR - Argentina 117
PL - Polonia 115
CA - Canada 113
IQ - Iraq 84
NL - Olanda 83
MX - Messico 68
AT - Austria 63
BE - Belgio 53
ZA - Sudafrica 45
CO - Colombia 40
ES - Italia 38
PK - Pakistan 38
MA - Marocco 31
UZ - Uzbekistan 29
EC - Ecuador 27
KR - Corea 27
VE - Venezuela 27
JO - Giordania 26
SA - Arabia Saudita 26
IR - Iran 25
LT - Lituania 25
EG - Egitto 23
AU - Australia 21
ET - Etiopia 18
EU - Europa 18
TN - Tunisia 18
JM - Giamaica 17
PH - Filippine 17
CL - Cile 16
IL - Israele 16
PY - Paraguay 16
CZ - Repubblica Ceca 14
PE - Perù 14
AE - Emirati Arabi Uniti 13
CH - Svizzera 13
KE - Kenya 13
BG - Bulgaria 12
AZ - Azerbaigian 11
HN - Honduras 11
MY - Malesia 10
NP - Nepal 10
DZ - Algeria 9
HU - Ungheria 9
KZ - Kazakistan 9
AL - Albania 8
CR - Costa Rica 8
DO - Repubblica Dominicana 8
LB - Libano 8
LV - Lettonia 8
MD - Moldavia 8
RO - Romania 8
NO - Norvegia 7
QA - Qatar 7
TW - Taiwan 7
BY - Bielorussia 6
CI - Costa d'Avorio 6
GR - Grecia 6
UY - Uruguay 6
DK - Danimarca 5
HR - Croazia 5
KG - Kirghizistan 5
LU - Lussemburgo 5
MN - Mongolia 5
NI - Nicaragua 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
SN - Senegal 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
LA - Repubblica Popolare Democratica del Laos 4
NG - Nigeria 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
TT - Trinidad e Tobago 4
BB - Barbados 3
BO - Bolivia 3
BS - Bahamas 3
EE - Estonia 3
Totale 26.968
Città #
Singapore 1.837
Chandler 1.514
Ashburn 993
San Jose 974
New York 365
Beijing 343
San Mateo 338
Jacksonville 329
Dublin 315
Los Angeles 219
Nanjing 217
Nürnberg 216
Ho Chi Minh City 207
Jakarta 206
Lauterbourg 196
Wilmington 177
Ann Arbor 165
Hanoi 165
Munich 159
Milan 155
Boston 145
Hefei 127
Tokyo 127
Frankfurt am Main 123
Marseille 123
Dearborn 122
Hong Kong 111
Moscow 111
Cattolica 110
Dallas 110
Nanchang 105
Woodbridge 100
Houston 99
Lawrence 93
Santa Clara 92
Princeton 80
The Dalles 74
São Paulo 73
Izmir 72
Lancaster 72
Seattle 72
Buffalo 71
Rome 70
Chicago 67
Redwood City 65
Warsaw 60
Bremen 52
Brussels 51
Fairfield 51
Shanghai 50
Detroit 49
Hebei 49
Vienna 49
London 48
Helsinki 47
Mountain View 44
Leawood 40
Kunming 38
Orem 38
Shenyang 37
Kent 36
Kraków 36
Brooklyn 35
Nuremberg 35
Paris 35
San Francisco 35
Amsterdam 34
Changsha 34
Phoenix 34
St Louis 34
Boardman 33
Zhengzhou 32
Baghdad 31
Tianjin 31
University Park 31
Atlanta 30
Rio de Janeiro 30
Augusta 29
Da Nang 29
Norwalk 28
Tashkent 27
Jiaxing 26
Johannesburg 26
Philadelphia 26
Redmond 26
Belo Horizonte 25
Düsseldorf 25
Turku 25
Andover 24
Haiphong 24
Montreal 24
Amman 23
Hangzhou 23
Pune 23
Seoul 23
Chennai 22
Toronto 22
Denver 21
Washington 21
Brasília 20
Totale 13.335
Nome #
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 354
Comparison of Right and Left Upper Limb Arterial Variants in Patients Undergoing Bilateral Transradial Procedures 272
Safety and efficacy of G-CSF in patients with ischemic heart failure: The CORNER (Cell Option for Recovery in the Non-Eligible patients for Revascularization) study. 264
Thrombus aspiration in ST elevation myocardial infarction: comparative efficacy in patients treated early and late after onset of symptoms. 258
Frequency domain optical coherence tomography to assess non-ostial left main coronary artery 251
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. 248
Renal artery stenting in patients with chronic ischemic heart disease 246
Baseline C-Reactive Protein Serum Levels and In-Stent Restenosis Pattern After m-TOR Inhibitors Drug-Eluting Stent Implantation 243
The HEART study: a real-world experience using the CID Chrono Carbostent in primary and rescue PCI 243
Ticagrelor and preconditioning in patients with stable coronary artery disease (TAPER-S): A randomized pilot clinical trial 240
Differences in Microparticle Release in Patients With Acute Coronary Syndrome and Stable Angina 238
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 236
Cystatin C is associated with an increased coronary atherosclerotic burden and a stable plaque phenotype in patients with ischemic heart disease and normal glomerular filtration rate 230
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 220
Outcome of non-cardiac surgery after stent implantation in the DES era: results of the Surgery After Stent (SAS) registry 218
Pre-intervention eosinophil cationic protein serum levels predict clinical outcomes following implantation of drug-eluting stents 214
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures 213
Angiographic and clinical outcome of percutaneous coronary intervention for in-stent restenosis of bifurcated lesions 210
Impact of coronary stenting on top of medical therapy and of inclusion of periprocedural infarctions on hard composite endpoints in patients with chronic coronary syndromes: a meta-analysis of randomized controlled trials 207
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 206
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 201
Euroscore as predictor of in-hospital mortality after percutaneous coronary intervention 201
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 200
Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling 198
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 194
Characterization of microvascular and myocardial damage within perfusion defect area at myocardial contrast echocardiography in the subacute phase of myocardial infarction 192
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry 192
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 192
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 191
Prospective randomized comparison of sirolimus- or everolimus-eluting stent to treat bifurcated lesions by provisional approach 189
A current approach to heart failure in Duchenne muscular dystrophy 187
Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease 184
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention 182
Are endothelial progenitor cells mobilized by myocardial ischemia or myocardial necrosis? A cardiac magnetic resonance study 181
Coronary Atherosclerotic Phenotype and Plaque Healing in Patients with Recurrent Acute Coronary Syndromes Compared with Patients with Long-term Clinical Stability: An in Vivo Optical Coherence Tomography Study 181
Impact of gender on clinical outcomes after mTOR-inhibitor drug-eluting stent implantation in patients with first manifestation of ischaemic heart disease 181
Left anterior descending artery percutaneous coronary intervention from the right radial access via the left internal mammary artery: A case report 180
Angiographically intermediate left main bifurcation disease assessment by frequency domain optical coherence tomography (FD-OCT) 179
Myocardial bridge evaluation towards personalized medicine: study design and preliminary results of the RIALTO registry 177
Coronary bifurcation lesions: to stent one branch or both? A meta-analysis of patients treated with drug eluting stents. 177
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 177
Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR: The Hostile Registry 175
Eosinophil cationic protein and clinical outcome after bare metal stent implantation 174
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 174
Efficacy of contrast medium induced Pd/Pa ratio in predicting functional significance of intermediate coronary artery stenosis assessed by fractional flow reserve: insights from the RINASCI study 172
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome 171
Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome 170
Concordance of angiographic and electrocardiographic indexes of microvascular obstruction: myocardial haemorrhage role 169
Clopidogrel-induced neutropenia after coronary stenting: is cilostazol a good alternative? 168
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion 168
Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study 166
Parvovirus B19 at the culprit coronary stenosis predicts outcome after stenting 166
Ethanol abolishes ischemic preconditioning in humans 165
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: A prospective study 163
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy 163
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 163
Resolute zotarolimus-eluting stent to treat bifurcated lesions according to the provisional technique: a procedural performance comparison with sirolimus- and everolimus-eluting stents 163
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial 163
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 162
Angiographic assessment of microvascular perfusion--myocardial blush in clinical practice 161
Influence of the amount of myocardium subtended by a stenosis on fractional flow reserve 159
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 156
No-reflow reversibility: a study based on serial assessment of multiple biomarkers 156
EuroSCORE predicts long-term mortality of unselected patients undergoing percutaneous coronary interventions 155
Three-dimensional quantitative coronary angiography and quantification of jeopardised myocardium to predict functional significance of intermediate coronary artery stenosis 154
Blood lactate predicts survival after percutaneous implantation of extracorporeal life support for refractory cardiac arrest or cardiogenic shock complicating acute coronary syndrome: insights from the CareGem registry 154
Predictors of periprocedural (type IVa) myocardial infarction, as assessed by frequency-domain optical coherence tomography 152
Radial artery complications occurring after transradial coronary procedures using long hydrophilic-coated introducer sheath: a frequency domain-optical coherence tomography study 152
Endothelial progenitor cells, microvascular obstruction, and left ventricular remodeling in patients with ST elevation myocardial infarction undergoing primary percutaneous coronary intervention 152
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events 149
Glucose-6-Phosphate Dehydrogenase (G6PDH) Deficiency in a Patient with ST-Segment Elevation Acute Myocardial Infarction Successfully Treated by Simple Thrombectomy 148
A meta-analysis of first-generation drug-eluting vs bare-metal stents for coronary chronic total occlusion: effect of length of follow-up on clinical outcome 147
Association between inflammatory biomarkers and in-stent restenosis tissue features: an Optical Coherence Tomography Study 147
Frequency-domain optical coherence tomography assessment of kissing-balloon effects in bifurcated coronary artery lesions undergoing provisional stenting 146
Long-term morphofunctional remodeling of internal thoracic artery grafts: a frequency-domain optical coherence tomography study 145
Optimizing Management of Stable Angina: A Patient-Centered Approach Integrating Revascularization, Medical Therapy, and Lifestyle Interventions 144
Microparticles in health and disease: small mediators, large role? 144
Management and timing of access-site vascular complications occurring after trans-radial percutaneous coronary procedures 143
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation 140
Quantitative Blush Evaluator accurately quantifies microvascular dysfunction in patients with ST-elevation myocardial infarction: comparison with cardiovascular magnetic resonance 139
Open-label, randomized, placebo-controlled evaluation of intracoronary adenosine or nitroprusside after thrombus aspiration during primary percutaneous coronary intervention for the prevention of microvascular obstruction in acute myocardial infarction: the REOPEN-AMI study (Intracoronary Nitroprusside Versus Adenosine in Acute Myocardial Infarction) 139
Optical coherence tomography in coronary atherosclerosis assessment and intervention 137
Excimer laser for a highly stenotic saphenous vein graft: evidence of debulking by optical coherence tomography 136
Dual role of circulating endothelial progenitor cells in stent struts endothelialisation and neointimal regrowth: a substudy of the IN-PACT CORO trial 136
The Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO in Predicting FFR (MEMENTOFFR) Study 136
Radial artery intima-media ratio predicts presence of coronary thin-cap fibroatheroma: a frequency domain-optical coherence tomography study 135
Coronary Stenosis as an Innocent Bystander in Acute Coronary Syndrome 134
Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction 133
Intracoronary microparticles and microvascular obstruction in patients with ST elevation myocardial infarction undergoing primary percutaneous intervention 131
Clinical impact of suboptimal stenting and residual intrastent plaque/thrombus protrusion in patients with acute coronary syndrome 131
Coronary plaque instability assessed by positron emission tomography and optical coherence tomography 130
Frequency-domain optical coherence tomography findings in patients with bifurcated lesions undergoing provisional stenting 129
Predictors of myocardial microvascular obstruction in patients treated by primary percutaneous coronary intervention and a short ischemic time 128
Baseline inflammatory status and long-term changes in renal function after percutaneous renal artery stenting: a prospective study 128
Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis 128
Characterization and Management of Stable Coronary Artery Disease in Patients Undergoing Transcatheter Aortic Valve Implantation 127
A case of variant angina in a patient under chronic treatment with sorafenib 127
One-year outcomes of consecutive patients treated by endeavor zotarolimus and resolute zotarolimus stents: The impact of polymer coating in drug-eluting stent technology 127
Functional coronary assessment in angina with intermediate coronary stenosis: the #FullPhysiology approach 126
Clinical outcome and correlates of coronary microvascular obstruction in latecomers after acute myocardial infarction 126
Totale 17.529
Categoria #
all - tutte 112.366
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.366


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.583 0 115 28 84 109 49 48 304 66 115 302 363
2022/20233.673 432 576 337 571 168 489 164 284 462 63 94 33
2023/20241.792 71 487 54 84 76 348 90 65 28 41 230 218
2024/20253.439 89 128 254 165 309 98 104 174 536 293 743 546
2025/20268.899 1.424 241 518 920 1.535 457 1.674 405 595 596 262 272
2026/2027916 338 578 0 0 0 0 0 0 0 0 0 0
Totale 27.376